Benitec Biopharma Ltd
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -103,961.7% | – | – | – | – | -1,533.9% | – | – | – | – | – | |
| – | – | 1,500.0% | – | – | – | – | 21.2% | – | – | – | – | – | |
| – | – | 3,200.0% | – | – | – | – | 2,419.2% | – | – | – | – | – | |
| – | – | -36,041.7% | – | – | – | – | -989.7% | – | – | – | – | – | |
| – | – | 2,990.4% | – | – | – | – | 0.1% | – | – | – | – | – | |
| – | – | -2,990.4% | – | – | – | – | -0.1% | – | – | – | – | – | |
| – | – | 2,581.4% | – | – | – | – | 769.6% | – | – | – | – | – | |
| – | – | -103,866.7% | – | – | – | – | -1,041.2% | – | – | – | – | – | |
| – | – | -106,952.1% | – | – | – | – | -1,534.0% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.